Abstract:Graft use in vaginal prolapse surgery has become more common secondary to high failure rates seen with traditional repairs. Mesh has been shown to be successful when suspending the upper portion of the vagina with sacralcolpopexy and its use vaginally is in an attempt to reproduce those results seen from the more invasive abdominal approach. A recent Cochrane review has supported its use in the anterior compartment vaginally as lower failure rates have been shown. Vaginal mesh “kits” have been developed in an … Show more
“…The vaginal epithelium should be well estrogenized both pre- and postoperatively with estrogen cream if necessary. (23) An additional consideration that has been noted in the literature is that of hypersensitivity reactions to synthetic transvaginal mesh. A case-controlled study that included the histological and immunohistochemical analysis of vaginal synthetic mesh explantations in a small population of women noted markers of humorally mediated lymphocytic reaction.…”
Section: Contraindications Of Mesh In Surgical Treatment Of Pelvic Ormentioning
Women are seeking care for pelvic organ prolapse (POP) in increasing numbers and a significant proportion of them will undergo a second repair for recurrence. This has initiated interest by both surgeons and industry to utilize and design prosthetic mesh materials to help augment longevity of prolapse repairs. Unfortunately, the introduction of transvaginal synthetic mesh kits for use in women was done without the benefit of Level 1 data to determine its utility compared to native tissue repair. This report summarizes the potential benefit/risks of transvaginal synthetic mesh use for POP and recommendations regarding its continued use.
“…The vaginal epithelium should be well estrogenized both pre- and postoperatively with estrogen cream if necessary. (23) An additional consideration that has been noted in the literature is that of hypersensitivity reactions to synthetic transvaginal mesh. A case-controlled study that included the histological and immunohistochemical analysis of vaginal synthetic mesh explantations in a small population of women noted markers of humorally mediated lymphocytic reaction.…”
Section: Contraindications Of Mesh In Surgical Treatment Of Pelvic Ormentioning
Women are seeking care for pelvic organ prolapse (POP) in increasing numbers and a significant proportion of them will undergo a second repair for recurrence. This has initiated interest by both surgeons and industry to utilize and design prosthetic mesh materials to help augment longevity of prolapse repairs. Unfortunately, the introduction of transvaginal synthetic mesh kits for use in women was done without the benefit of Level 1 data to determine its utility compared to native tissue repair. This report summarizes the potential benefit/risks of transvaginal synthetic mesh use for POP and recommendations regarding its continued use.
“…Furthermore, seven of the seventeen women were noted to have vaginal tightness, and five of the seventeen women reported vaginal shortening [6, 17]. Moore and Miklos discuss the importance of avoiding tension on the levator ani muscle and ligamentous attachments as well as minimizing vaginal epithelium excision and maximizing vaginal estrogen both pre- and postoperatively [23]. Ideal graft augmentation and the avoidance of tensioning can still be complicated by scar tissue formation which may vary from patient to patient.…”
Section: Complications Of Vaginal Mesh Procedures In the Treatmentmentioning
Synthetic transvaginal mesh has been employed in the treatment of pelvic organ prolapse for more than a decade. As the use of these devices increased during this period so did adverse event reporting. In 2008, the Food and Drug Administration (FDA) Public Health Notification informed physicians and patients of rising concerns with the use of synthetic transvaginal mesh. Shortly thereafter and in parallel to marked increases in adverse event reporting within the Manufacturer and User Device Experience (MAUDE), the FDA released a Safety Communication regarding urogynecologic surgical mesh use. Following this report and in the wake of increased medical industry product withdrawal, growing medicolegal concerns, patient safety, and clinical practice controversy, many gynecologists and pelvic reconstructive surgeons are left with limited long-term data, clinical guidance, and growing uncertainty regarding the role of synthetic transvaginal mesh use in pelvic organ prolapse. This paper reviews the reported complications of synthetic transvaginal mesh with an evidence-based approach as well as providing suggested guidance for the future role of its use amidst the controversy.
Tailoring surgical decision-making for the individual patient must take into account and balance the patient's anatomy, symptoms, and functional status. Repairing anatomy alone is not the only important factor. The use of synthetic materials in prolapse repair demands critical examination, given the devastating complications that can occur.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.